Informações:
Falhas:
ID
35014
Descrição
An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02380209
Link
https://clinicaltrials.gov/show/NCT02380209
Palavras-chave
Versões (1)
- 09/02/2019 09/02/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
9 de fevereiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT02380209
Eligibility Breast Cancer NCT02380209
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT02380209
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Invasive Ductal Breast Carcinoma
Item
newly diagnosed infiltrating ductal carcinoma (idc) of the breast
boolean
C1134719 (UMLS CUI [1])
Primary tumor Size
Item
>= 1.0 cm primary tumor
boolean
C0677930 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,2])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
calculated creatinine clearance >= 50 ml/min
boolean
C2711451 (UMLS CUI [1])
Informed Consent
Item
willing and able to provide informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Patient Information Study Protocol
Item
informed of the investigational nature of this study
boolean
C1955348 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])
Hypersensitivity Iodinated contrast dye
Item
allergy to iodinated contrast agent
boolean
C0020517 (UMLS CUI [1,1])
C0879373 (UMLS CUI [1,2])
C0879373 (UMLS CUI [1,2])
Metformin | Aminoglycosides | Pharmaceutical Preparations Nephrotoxic | NSAIDs Daily
Item
use of metformin, aminoglycosides, other nephrotoxic medications, or daily use of nsaids
boolean
C0025598 (UMLS CUI [1])
C0002556 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C1514118 (UMLS CUI [3,2])
C0003211 (UMLS CUI [4,1])
C0332173 (UMLS CUI [4,2])
C0002556 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C1514118 (UMLS CUI [3,2])
C0003211 (UMLS CUI [4,1])
C0332173 (UMLS CUI [4,2])
Diabetes Mellitus
Item
diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Claustrophobia Severe
Item
history of severe claustrophobia
boolean
C0008909 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Implants Exclude MRI | Artificial cardiac pacemaker | Cochlear Implants | Surgical Clips Magnetic | Prosthesis
Item
presence of electrically, magnetically, or mechanically activated implants including cardiac pacemakers, cochlear implants, magnetic surgical clips or prosthesis that would preclude mri
boolean
C0021102 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
C0030163 (UMLS CUI [2])
C0009199 (UMLS CUI [3])
C0038917 (UMLS CUI [4,1])
C0563532 (UMLS CUI [4,2])
C0175649 (UMLS CUI [5])
C0332196 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
C0030163 (UMLS CUI [2])
C0009199 (UMLS CUI [3])
C0038917 (UMLS CUI [4,1])
C0563532 (UMLS CUI [4,2])
C0175649 (UMLS CUI [5])
Antihypertensive Agents Quantity
Item
use of > 1 antihypertensive drug
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Paraproteinemias | Multiple Myeloma
Item
paraproteinemia syndromes or multiple myeloma
boolean
C0030489 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
C0026764 (UMLS CUI [2])
Collagen-vascular disease
Item
collagen vascular disease
boolean
C0262428 (UMLS CUI [1])
Hyperthyroidism
Item
active hyperthyroidism
boolean
C0020550 (UMLS CUI [1])
Pharmacotherapy Malignant Neoplasms
Item
active pharmaceutical treatments for cancer
boolean
C0013216 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,2])